La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Astrana Health Résultats passés
Passé contrôle des critères 5/6
Astrana Health a connu une croissance annuelle moyenne de ses bénéfices de 22.6%, tandis que le secteur Healthcare a vu ses bénéfices augmenter de en hausse à 7.1% par an. Les revenus ont augmenté de en hausse à un taux moyen de 23% par an. Le rendement des capitaux propres de Astrana Health est 13.9% et ses marges nettes sont de 4.3%.
Informations clés
22.6%
Taux de croissance des bénéfices
17.6%
Taux de croissance du BPA
Healthcare Croissance de l'industrie | 8.5% |
Taux de croissance des recettes | 23.0% |
Rendement des fonds propres | 13.9% |
Marge nette | 4.3% |
Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan
Sep 26A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Sep 21The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising
Sep 06With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case
Aug 22Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance
Aug 04Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Aug 04Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 17Ventilation des recettes et des dépenses
Comment Astrana Health gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 1,592 | 68 | 142 | 0 |
31 Mar 24 | 1,454 | 62 | 130 | 0 |
31 Dec 23 | 1,387 | 61 | 113 | 0 |
30 Sep 23 | 1,328 | 45 | 99 | 0 |
30 Jun 23 | 1,297 | 46 | 91 | 0 |
31 Mar 23 | 1,218 | 45 | 87 | 0 |
31 Dec 22 | 1,144 | 45 | 78 | 0 |
30 Sep 22 | 1,045 | 58 | 67 | 0 |
30 Jun 22 | 955 | 69 | 68 | 0 |
31 Mar 22 | 861 | 70 | 62 | 0 |
31 Dec 21 | 774 | 69 | 62 | 0 |
30 Sep 21 | 756 | 70 | 55 | 0 |
30 Jun 21 | 709 | 53 | 49 | 0 |
31 Mar 21 | 698 | 47 | 47 | 0 |
31 Dec 20 | 687 | 38 | 49 | 0 |
30 Sep 20 | 689 | 35 | 51 | 0 |
30 Jun 20 | 665 | 22 | 43 | 0 |
31 Mar 20 | 630 | 18 | 41 | 0 |
31 Dec 19 | 561 | 14 | 40 | 0 |
30 Sep 19 | 488 | 4 | 44 | 0 |
30 Jun 19 | 499 | 10 | 45 | 0 |
31 Mar 19 | 492 | 9 | 46 | 0 |
31 Dec 18 | 520 | 11 | 47 | 0 |
30 Sep 18 | 506 | 28 | 42 | 0 |
30 Jun 18 | 436 | 24 | 38 | 0 |
31 Mar 18 | 395 | 24 | 33 | 0 |
31 Dec 17 | 356 | 26 | 26 | 0 |
30 Sep 17 | 336 | 13 | 22 | 0 |
30 Jun 17 | 323 | 11 | 23 | 0 |
31 Mar 17 | 317 | 12 | 22 | 0 |
31 Dec 16 | 306 | 11 | 21 | 0 |
31 Dec 15 | 313 | 13 | 27 | 0 |
31 Dec 14 | 134 | -1 | 36 | 0 |
Des revenus de qualité: ASTH a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: ASTH's current net profit margins (4.3%) are higher than last year (3.5%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: ASTH's earnings have grown significantly by 22.6% per year over the past 5 years.
Accélération de la croissance: La croissance des bénéfices de ASTH au cours de l'année écoulée ( 49.5% ) dépasse sa moyenne sur 5 ans ( 22.6% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices ASTH au cours de l'année écoulée ( 49.5% ) a dépassé celle du secteur Healthcare 6%.
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de ASTH ( 13.9% ) est considéré comme faible.